August 24, 2014 | Israeli biotechnology company NeuroDerm raised $16 million in investments to continue working on its wearable treatment for Parkinson’s disease. The financing round was led by existing investors. The company is currently in the midst of a mid-stage study for its treatment for neurodegenerative disease, a belt pump that is worn around the waist and continuously administers Parkinson’s drugs for the most severe cases. The company and the testing of their Phase II treatment received a $1 million from the Michael J. Fox Foundation for Parkinson’s Research.